Sanofi’s Multiple Sclerosis Drug Gains European Approval After Setbacks in the U.S.
Sanofi, a leading French pharmaceutical company, has received positive news about its multiple sclerosis (MS) drug called tolebrutinib. The European […]
Sanofi, a leading French pharmaceutical company, has received positive news about its multiple sclerosis (MS) drug called tolebrutinib. The European […]
A clinical trial for a new personalized cancer vaccine called TG4050 has reached a key step. The study, which is
A new experimental medication called adibelivir (IM-250), developed by Innovative Molecules, is showing strong potential in early studies to treat
A new and exciting type of medical treatment called ‘in vivo cell therapy’ is now being tested for the first
Eli Lilly, the company behind the newly approved obesity medication called Foundayo (also known as orforglipron), has shared exciting new
A recent study has found that using food packaging films to store certain medications can help maintain their stability, especially
Amgen, a biotechnology company, has shared promising results from a large clinical trial (Phase 3) testing a new under-the-skin injection
Two major drug companies, Eli Lilly and Eisai, are defending their Alzheimer’s disease treatments after a new review suggested they
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new medication called Kerendia (finerenone) for adults with
Gilead Sciences, a well-known pharmaceutical company, has agreed to purchase Tubulis, a German biotechnology company, for $3.15 billion upfront. This